Navigation Links
Court Fines Newspaper for Revealing AIDS Orphan's Identity

A Beijing court has ordered a local newspaper to pay compensation and apologise to a young woman orphaned by AIDS for revealing her identity and for unethical reporting.//

Beijing Chaoyang District Court ordered the local China Times to pay the 19-year-old woman 20,000 yuan (2,500 US dollars) and issue an apology on its front page for a report published last December.

The report carried three photos of the woman and the story of her sufferings after her parents, who contracted AIDS after selling blood, died earlier this decade.

The reporter, identified by his family name, Hu was accused of violating the young woman's privacy and damaging her reputation as the photos clearly revealed her face and carried her real name.

Although the daily was not the first to report the woman's story, Hu never interviewed the young woman and he bought her photos from a website.

His story was scalped from other news reports and the woman's own anonymous writings on the Internet.

His later insistence that he had done nothing improper outraged Jin Wei, an AIDS activist who supported the woman's education.

After her identity was revealed the young woman's grades dropped sharply and she lost confidence in herself, Jin was quoted as saying by Xinhua news agency.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
2. Bihar High Court Intervenes To End Doctors Strike
3. High Court Issues Notice To Centre On Smoking Ban In Films
4. Madras High Court Disapproves of Comparative Advertisements
5. Another British Woman In Court For New Breast Cancer Drug
6. Fizzy Logic For A Perfect Drink: Courtesy Boffins
7. Australian Court Finds Man Guilty of Spreading HIV/AIDS
8. Dare Not Mercy kill – Courtesy: The Care Not Killing Grou
9. Court Orders Private Hospitals To Provide Free Treatment For The Poor
10. Courting Couples Use Valentine’s Day Threat to Their Advantag
11. Mental Health Court Established
Post Your Comments:
(Date:12/2/2008)... , National Non-profit La...that Provides Eye Exams at No Cost to Eligible Pat... San Francisco, CA (Vocus) December 2...eniors who suffer with an eye disease known as Age...always, "No.", , , , ,Picture this&hell...
(Date:12/2/2008)... , Liberty Mutual Provide...ms at www.BeFireSmart.com , ...ty Mutual Insurance and Holly Robinson Peete , a...ming up to encourage families to set aside a few m...ty precautions and response plans at BeFireSmart.c...
(Date:12/1/2008)... SOUTH BEND, Ind., Dec. 2 Patient...cilities are on the rise according to a new report...atient Pulse Report: Patient,Perspectives on Amer...,facilities as a driver for improvement in patien...ore than 2 million patients treated at more than,...
(Date:12/1/2008)... , CHICAGO New research has found that the avail...phy (CT) scanner in an emergency room can signific...ceive a potentially life-saving treatment. Results...nter (NSMC)-Salem Hospital in Salem, Mass., will b...iological Society of North America (RSNA). , "T...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...udy shows the anti-inflammatory drug naproxen may ...a non-steroidal anti-inflammatory drug (NSAID) com...y and arthritic conditions. Researchers in Quebec ...Ds //in the prevention of acute myocardial infarct...
...cessfully used gene therapy to restore sight to an...eam of scientists led by Jean Bennett, at the Univ...this month's Nature Genetics.Their experiment invo...a form of blindness, that also affects human infan...
...hicago, studied the use of a ginseng extract for t...een shown to have many beneficial effects on healt...he condition affects about 8% of the U.S. populati...he vast majority of people with diabetes more than...
...t that acupuncture is at least as safe as conventi...n the safety of complementary and alternative medi... one of the first serious safety assessments on ac...d physiotherapists carrying out acupuncture agreed...
Other Medicine News:
(Date:12/1/2008)...Dec. 1 Genaera Corporat...of subjects has begun in study MSI-1436C-102 (Stud... of trodusquemine (MSI-1436) in overweight and obe...ic for the treatment of type 2 diabetes and obesit...te insulin and leptin pathways through the highly ...
(Date:11/30/2008)...c. 1 Older adults who e...ow and a greater number of small blood vessels in ...t the annual meeting of the Radiological Society o...ducted at the University of North Carolina ( UNC...ans of older adults who exercise to brain scans of...
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...pondents against expanding statin use broadly in w..., N.J., Nov. 25 JUPITER, a clinica...iovascular risk of healthy patients with elevated ...er adults, according to a national poll directed a...ok part in the online poll conducted by medical ne...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 1Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 2Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 3VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 1VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 2VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 3A young star in childhood cancer research 6974 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 2
...07 – On 23 July SYGNIS Pharma,AG will presen...AX200 (AXIS-study)., AX200, a compound for the tre...ate in SYGNIS’ product pipeline. The,primary...ty of,AX200 in acute stroke patients. The results ...ion for the further clinical,development of AX200....
...swire-FirstCall/ -- ImClone,Systems Incorporated a...sults from an open-label Phase III study of ERBITU...the first-line,treatment for metastatic non-small ...ts primary endpoint of progression-free,survival (...w,committee (IRRC). However, key secondary endpoin...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
Solid 8 mm blades. Dull finish. Most popular size or model.
Open 10 mm blades. Dull finish.
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model.
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: